Gregory E. Hardee
10Patents
7h-index
27Co-inventors
62Inventor score
Filing activity: Sep 11, 1995 → Jan 7, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6747014B2 | Compositions and methods for non-parenteral delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 76 | Expired |
| US5721359A | Crystalline ceftiofur free acid | Human Necessities | 58 | Expired |
| US8691785B2 | Compositions and methods for non-parenteral delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 48 | Active |
| US6841539B1 | Compositions and methods for topical delivery of oligonucleotides | Human Necessities | 20 | Expired |
| US8168600B2 | Compositions and methods for topical delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6083923A | Liposomal oligonucleotide compositions for modulating RAS gene expression | Chemistry; Metallurgy | 10 | Expired |
| US7576067B2 | Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption | Human Necessities | 9 | Expired |
| US8377897B2 | Compositions and methods for non-parenteral delivery of oligonucleotides | Chemistry; Metallurgy | 4 | Expired |
| US7964579B2 | Compositions and methods for topical delivery of oligonucleotides | Human Necessities | 4 | Active |
| US9173894B2 | Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF) | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.